S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
OTCMKTS:ABSCF

AB Science Stock Forecast, Price & News

$14.00
0.00 (0.00%)
(As of 11/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$14.00
$14.00
50-Day Range
$14.00
$16.10
52-Week Range
$8.65
$26.70
Volume
N/A
Average Volume
998 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive ABSCF News and Ratings via Email

Sign-up to receive the latest news and ratings for AB Science and its competitors with MarketBeat's FREE daily newsletter.


AB Science logo

About AB Science

AB Science SA engages in the research, development, and sales of protein kinase inhibitor drugs. It develops pharmaceutical products for the treatment of cancer, neurological, and inflammatory diseases. The firm's pipeline includes Masitinib and AB8939. The company was founded by Alain Moussy and Jean-Pierre Kinet on July 11, 2001 and is headquartered in Paris, France.

Headlines

AB Science (OTCMKTS:ABSCF) Trading Down 4.9%
November 9, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ABSCF
CIK
N/A
Fax
N/A
Employees
93
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












AB Science (OTCMKTS:ABSCF) Frequently Asked Questions

Is AB Science a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AB Science in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AB Science stock.
View analyst ratings for AB Science
or view top-rated stocks.

Who are AB Science's key executives?

AB Science's management team includes the following people:
  • Alain Moussy, Chairman & Chief Executive Officer
  • Laurent Guy, Chief Financial Officer
  • Antonello Cervone, Director-Information Technology
  • Christian Fassotte, Global Chief Medical Officer
  • Véronique Gélébart, Head-Clinical Operations & Clinical Development

What is AB Science's stock symbol?

AB Science trades on the OTCMKTS under the ticker symbol "ABSCF."

How do I buy shares of AB Science?

Shares of ABSCF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AB Science's stock price today?

One share of ABSCF stock can currently be purchased for approximately $14.00.

How many employees does AB Science have?

AB Science employs 93 workers across the globe.

What is AB Science's official website?

The official website for AB Science is www.ab-science.com.

Where are AB Science's headquarters?

AB Science is headquartered at 3, Avenue George V, Paris, Ile-de-France 75008.

How can I contact AB Science?

AB Science's mailing address is 3, Avenue George V, Paris, Ile-de-France 75008. The company can be reached via phone at (314) 720-0014.


This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.